NDC11 62135099917
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 62135-0999-17 | 62135-0999 |
| 62135-999-17 | 62135-999 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rizatriptan benzoate | RIZATRIPTAN BENZOATE | Chartwell RX, LLC | faf3bc1d-8818-47b0-8ad1-80bfbf40ab78 | 2026-09-13 | Warnings, Adverse reactions | 62135-999-17 62135-999 62135099917 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.